Header Logo

Connection

JOHN M SKIBBER to Neoplasm Staging

Back to Details
This is a "connection" page, showing publications JOHN M SKIBBER has written about Neoplasm Staging.
JOHN M SKIBBER
Connection Strength
0.738
Neoplasm Staging
  1. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation? Dis Colon Rectum. 2019 10; 62(10):1158-1166.
    View in: PubMed
    Score: 0.060
  2. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys. 1999 Jul 15; 44(5):1027-38.
    View in: PubMed
    Score: 0.059
  3. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum. 2012 Dec; 55(12):1213-9.
    View in: PubMed
    Score: 0.037
  4. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006 Jun; 29(3):219-24.
    View in: PubMed
    Score: 0.024
  5. Local excision for rectal cancer. J Natl Compr Canc Netw. 2005 Jul; 3(4):531-9.
    View in: PubMed
    Score: 0.022
  6. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer. 2022 03; 21(1):e28-e37.
    View in: PubMed
    Score: 0.017
  7. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol. 2001 Apr; 24(2):107-12.
    View in: PubMed
    Score: 0.017
  8. Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. Int J Radiat Oncol Biol Phys. 2001 Jan 01; 49(1):107-16.
    View in: PubMed
    Score: 0.016
  9. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2000 Jun 01; 47(3):713-8.
    View in: PubMed
    Score: 0.016
  10. Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 09 01; 17(9):1109-1133.
    View in: PubMed
    Score: 0.015
  11. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol. 1999 May; 51(2):153-60.
    View in: PubMed
    Score: 0.015
  12. Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol. 1999 Jan-Feb; 6(1):26-32.
    View in: PubMed
    Score: 0.014
  13. Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique. J Gastrointest Surg. 2018 11; 22(11):2013-2019.
    View in: PubMed
    Score: 0.014
  14. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 07; 16(7):874-901.
    View in: PubMed
    Score: 0.014
  15. Locally advanced rectal cancer: surgical complications after infusional chemotherapy and radiation therapy. Radiology. 1998 Jan; 206(1):131-6.
    View in: PubMed
    Score: 0.013
  16. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal. Am J Clin Oncol. 2017 Dec; 40(6):555-560.
    View in: PubMed
    Score: 0.013
  17. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 03; 15(3):370-398.
    View in: PubMed
    Score: 0.013
  18. Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy. J Natl Compr Canc Netw. 2016 12; 14(12):1528-1534.
    View in: PubMed
    Score: 0.012
  19. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer. 2017 04 01; 123(7):1124-1133.
    View in: PubMed
    Score: 0.012
  20. Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surg. 2015 Mar 01; 150(3):245-51.
    View in: PubMed
    Score: 0.011
  21. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015 Jan; 150(1):17-22.
    View in: PubMed
    Score: 0.011
  22. Incidence of minimally invasive colorectal cancer surgery at National Comprehensive Cancer Network centers. J Natl Cancer Inst. 2015 Jan; 107(1):362.
    View in: PubMed
    Score: 0.011
  23. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74.
    View in: PubMed
    Score: 0.011
  24. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014 Jun; 109(7):652-8.
    View in: PubMed
    Score: 0.010
  25. Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions. J Natl Compr Canc Netw. 2014 Feb; 12(2):235-43.
    View in: PubMed
    Score: 0.010
  26. Impact of ileostomy-related complications on the multidisciplinary treatment of rectal cancer. Ann Surg Oncol. 2014 Feb; 21(2):507-12.
    View in: PubMed
    Score: 0.010
  27. An individualized conditional survival calculator for patients with rectal cancer. Dis Colon Rectum. 2013 May; 56(5):551-9.
    View in: PubMed
    Score: 0.010
  28. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013 May 01; 11(5):519-28.
    View in: PubMed
    Score: 0.010
  29. Metformin use and improved response to therapy in rectal cancer. Cancer Med. 2013 Feb; 2(1):99-107.
    View in: PubMed
    Score: 0.009
  30. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2013 Feb; 56(2):135-41.
    View in: PubMed
    Score: 0.009
  31. Rectal cancer. J Natl Compr Canc Netw. 2012 Dec 01; 10(12):1528-64.
    View in: PubMed
    Score: 0.009
  32. Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis. J Clin Oncol. 2013 Jan 01; 31(1):30-8.
    View in: PubMed
    Score: 0.009
  33. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
    View in: PubMed
    Score: 0.009
  34. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012 May 20; 30(15):1770-6.
    View in: PubMed
    Score: 0.009
  35. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012 Sep; 19(9):2814-21.
    View in: PubMed
    Score: 0.009
  36. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation. Dis Colon Rectum. 2012 Apr; 55(4):371-7.
    View in: PubMed
    Score: 0.009
  37. Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146). Ann Surg Oncol. 2011 Sep; 18(9):2422-31.
    View in: PubMed
    Score: 0.008
  38. Meeting the 12 lymph node (LN) benchmark in colon cancer. J Surg Oncol. 2010 Jul 01; 102(1):3-9.
    View in: PubMed
    Score: 0.008
  39. NCCN clinical practice guidelines in oncology. Anal carcinoma. J Natl Compr Canc Netw. 2010 Jan; 8(1):106-20.
    View in: PubMed
    Score: 0.008
  40. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol. 2010 Feb; 17(2):441-7.
    View in: PubMed
    Score: 0.008
  41. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol. 2009 Dec 10; 27(35):5938-43.
    View in: PubMed
    Score: 0.008
  42. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw. 2009 Sep; 7(8):778-831.
    View in: PubMed
    Score: 0.007
  43. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009 Sep; 7(8):838-81.
    View in: PubMed
    Score: 0.007
  44. A twenty-year experience with adenocarcinoma of the anal canal. Dis Colon Rectum. 2009 Aug; 52(8):1375-80.
    View in: PubMed
    Score: 0.007
  45. Factors associated with sphincter-preserving surgery for rectal cancer at national comprehensive cancer network centers. Ann Surg. 2009 Aug; 250(2):260-7.
    View in: PubMed
    Score: 0.007
  46. Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):824-30.
    View in: PubMed
    Score: 0.007
  47. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol. 2008 Jan; 15(1):46-51.
    View in: PubMed
    Score: 0.007
  48. Colon cancer. J Natl Compr Canc Netw. 2007 Oct; 5(9):884-925.
    View in: PubMed
    Score: 0.007
  49. Rectal cancer. J Natl Compr Canc Netw. 2007 Oct; 5(9):940-81.
    View in: PubMed
    Score: 0.007
  50. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007 Aug; 246(2):215-21.
    View in: PubMed
    Score: 0.006
  51. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007 May 01; 109(9):1750-5.
    View in: PubMed
    Score: 0.006
  52. NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw. 2007 May; 5 Suppl 1:S1-22; quiz S23-2.
    View in: PubMed
    Score: 0.006
  53. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol. 2007 Jun; 14(6):1870-7.
    View in: PubMed
    Score: 0.006
  54. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007 Mar 21; 99(6):433-41.
    View in: PubMed
    Score: 0.006
  55. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):762-71.
    View in: PubMed
    Score: 0.006
  56. Colon cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005 Jul; 3(4):468-91.
    View in: PubMed
    Score: 0.006
  57. Rectal cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005 Jul; 3(4):492-508.
    View in: PubMed
    Score: 0.006
  58. Anal canal cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005 Jul; 3(4):510-5.
    View in: PubMed
    Score: 0.006
  59. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer. Prostate. 2005 Jan 01; 62(1):101-4.
    View in: PubMed
    Score: 0.005
  60. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1098-105.
    View in: PubMed
    Score: 0.005
  61. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys. 1995 Jul 15; 32(4):1025-9.
    View in: PubMed
    Score: 0.003
  62. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys. 1995 Apr 30; 32(1):197-204.
    View in: PubMed
    Score: 0.003
  63. Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. A report of surgical morbidity. Cancer. 1993 Jun 01; 71(11):3690-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.